Cathie's Ark Logo
undefined Logo

ARKK Holdings of Intellia Therapeutics (NTLA) - Updated Daily

Gene TherapyGenomicsSynthetic BiologyGene Base EditingCRSPR Gene Editing
Date
Direction
Shares
Fund Weight
Fund
July 15, 2024
BUY57.288k0.0236%ARKK
July 8, 2024
BUY163.542k0.0598%ARKK
July 5, 2024
BUY57.630k0.0208%ARKK
July 3, 2024
BUY19.124k0.007%ARKK
July 2, 2024
BUY141.505k0.0508%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
0.08%$2.57b
🏋🏿‍♂️Weight Rank In ARKK🌏Country
23🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
203$62.04
🎫ARK Ownership Percent
0.23%

Other ETFs That Hold NTLA

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.95%
ARKKARK Innovation ETF3.77%
GNOMGlobal X Genomics & Biotechnology ETF3.28%
XBISPDR® S&P Biotech ETF1.12%
IBBiShares Biotechnology ETF0.31%
LABUS&P Biotech Bull 3X Shares ETF0.24%

Research Notes and Commentary for NTLA

No Research Notes Found for NTLA